Role of Patient Input for Oncology Drug Reviews
An interview with Marjorie Morrison, CEO of the Canadian Cancer Action Network
Listen as Marjorie Morrison, CEO of the Canadian Cancer Action Network, talks about the important role patient advocacy groups are playing in today’s complex drug approval process and how the new Patient Health Technology Assessment Navigator is helping to shape the country’s drug review system.
Sign up to Canadian Oncology Clinical Trial News
Receive updates from our blog, podcasts and resource library.